Products

AmbroSpray:


Indication	AmbroSpray ® is indicated for the mucolytic treatment of acute and chronic bronchopulmonary diseases characterized by impaired mucous formation and transportation.
Advantages	UNIQUE & PATENTED formulation AmbroSpray® has a unique and patented formulation. PRECISE Spray presentation with a pharmaceutical-metered pump that delivers exactly 10mg per spray pump. Allows the therapeutic dose of 90 mg per day (3 puffs 3 times per day). HIGHEST CONCETRATION Only ambroxol has a 5% concentration; Mucosolvan® has only 0.6%. Practical and Easy to Use Small bottle that can comfortably be carried and easily be used. CLINICALLY PROVEN EFFICACY OF THE API Very well-known API with certified clinical effect. AmbroSpray® bioequivalence study vs. Mucosolvan® syrup.

Indication

AmbroSpray ® is indicated for the mucolytic treatment of acute and chronic bronchopulmonary diseases characterized by impaired mucous formation and transportation.

Advantages

UNIQUE & PATENTED formulation
AmbroSpray® has a unique and patented formulation.
PRECISE
Spray presentation with a pharmaceutical-metered pump that delivers exactly 10mg per spray pump. Allows the therapeutic dose of 90 mg per day (3 puffs 3 times per day).
HIGHEST CONCETRATION
Only ambroxol has a 5% concentration; Mucosolvan® has only 0.6%. Practical and Easy to Use Small bottle that can comfortably be carried and easily be used.
CLINICALLY PROVEN EFFICACY OF THE API
Very well-known API with certified clinical effect. AmbroSpray® bioequivalence study vs. Mucosolvan® syrup.

Vardenafil 10 mg Orodispersible Tablets:


Indication	Treatment of erectile dysfunction in adult men. Erectile dysfunction is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.
API	Vardenafil Hydrochloride Trihydrate
Dosage	10 mg/Tablet
Formulation	Orodispersible Tablets
Shelf life	36 months
Place of production	UK
Patients	Adult men
Posology	Approximately 25 to 60 minutes before sexual activity.